- Home
- SOAR vs XAIR Comparison
SOAR vs XAIR Comparison
Compare SOAR & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOAR | XAIR |
|---|---|---|
| Founded | 2021 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 5.4M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | SOAR | XAIR |
|---|---|---|
| Price | $0.23 | $0.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 6.2M | 330.7K |
| Earning Date | 05-14-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.09 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,705,000.00 |
| Revenue This Year | N/A | $122.00 |
| Revenue Next Year | N/A | $58.15 |
| P/E Ratio | $0.28 | ★ N/A |
| Revenue Growth | N/A | ★ 219.67 |
| 52 Week Low | $0.19 | $0.15 |
| 52 Week High | $4.36 | $3.78 |
Technical Indicators
Market Signals| Indicator | SOAR | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 40.89 | 35.12 |
| Support Level | $0.20 | $0.43 |
| Resistance Level | $0.35 | $0.82 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 24.29 | 19.85 |
Price Performance
Historical ComparisonAbout SOAR Volato Group Inc.
Volato Group Inc operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.